Search Results - "JURION, F"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis by D'SOUZA, S, ROSSEELS, V, ROMANO, M, TANGHE, A, DENIS, O, JURION, F, CASTIGLIONE, N, VANONCKELEN, A, PALFLIET, K, HUYGEN, Kris

    Published in Infection and Immunity (01-01-2003)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids by D'Souza, S, Rosseels, V, Denis, O, Tanghe, A, De Smet, N, Jurion, F, Palfliet, K, Castiglioni, N, Vanonckelen, A, Wheeler, C, Huygen, K

    Published in Infection and Immunity (01-07-2002)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary? by Zlotta, A R, van Vooren, J P, Huygen, K, Drowart, A, Decock, M, Pirson, M, Jurion, F, Palfliet, K, Denis, O, Simon, J, Schulman, C C

    Published in European urology (01-04-2000)
    “…For more than 20 years, BCG intravesical therapy schedule has included 6 weekly instillations. Very few studies have, however, analyzed the rationale of this…”
    Get more information
    Journal Article
  4. 4

    Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG by HUYGEN, K, LOZES, E, DE BRUYN, J, VAN VOOREN, J.-P, DELEYS, R, GILLES, B, DROWART, A, PALFLIET, K, JURION, F, ROLAND, I, ART, M, DUFAUX, M, NYABENDA, J

    Published in Infection and Immunity (01-02-1994)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cross‐Reactive Immune Responses Against Mycobacterium bovis BCG in Mice Infected with Non‐Tuberculous Mycobacteria Belonging to the MAIS‐Group by LOZES, E., DENIS, O., DROWART, A., JURION, F., PALFLIET, K., VANONCKELEN, A., DE BRUYN, J., DE COCK, M., VAN VOOREN, J.‐P., HUYGEN, K.

    Published in Scandinavian journal of immunology (01-07-1997)
    “…Two bacillus Calmette–Guérin (BCG)‐susceptible mouse strains, BALB/c and C57BL/6, were infected intravenously with Mycobacterium intracellulare, M. avium or M…”
    Get full text
    Journal Article
  7. 7
  8. 8

    H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin by HUYGEN, K, PALFLIET, K, JURION, F, HILGERS, J, TEN BERG, R, VAN VOOREN, J.-P, DE BRUYN, J

    Published in Infection and Immunity (01-12-1988)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Antibody repertoire against culture filtrate antigens in wild house mice infected with Mycobacterium bovis BCG by HUYGEN, K., PALFLIET, K., JURION, F., LENOIR, C., VOOREN, J‐P.

    Published in Clinical and experimental immunology (01-11-1990)
    “…SUMMARY Wild house mice (Mus domesticus) captured in a Flemish pigsty were infected intravenously with 4 × l06 viable units of Mycobacterium bovis BCG and…”
    Get full text
    Journal Article
  10. 10

    Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection by DENIS, O, TANGHE, A, HUYGEN, K, PALFLIET, K, JURION, F, VAN DEN BERG, T.-P, VANONCKELEN, A, OOMS, J, SAMAN, E, ULMER, J. B, CONTENT, J

    Published in Infection and immunity (01-04-1998)
    “…Vaccination of mice with plasmid DNA carrying the gene for the major secreted mycobacterial antigen 85A (Ag85A) from Mycobacterium tuberculosis is a powerful…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Six Adult Cases with a Pseudo-Vestibular Syndrome Related to Vergence Abnormalities by Yang, Q., Jurion, F., Bucci, M. P., Lucek, A., Wiener-Vacher, S., Brémond-Gignac, D., Orssaud, C., Kapoula, Z.

    “…Saccades and vergence were studied in adults with vertigo but without abnormal vestibular function; vertigo was associated with headaches and occurred mostly…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy by Zlotta, A R, Drowart, A, Van Vooren, J P, Shekarsarai, H, De Cock, M, Pirson, M, Palfliet, K, Jurion, F, Simon, J, Schulman, C C, Huygen, K

    Published in The Journal of urology (01-06-1998)
    “…The precise mechanism of action of bacillus Calmette-Guerin (BCG) in bladder cancer treatment remains poorly understood. Whether bladder tumor cells are…”
    Get more information
    Journal Article
  18. 18

    Six Adult Cases with a Pseudo-Vestibular Syndrome Related to Vergence Abnormalities by Yang, Q., Jurion, F., Bucci, M. P., Lucek, A., Wiener-Vacher, S., Brémond-Gignac, D., Orssaud, C., Kapoula, Z.

    Published in Neuro-Ophthalmology (01-01-2008)
    “…Saccades and vergence were studied in adults with vertigo but without abnormal vestibular function; vertigo was associated with headaches and occurred mostly…”
    Get full text
    Report
  19. 19
  20. 20

    The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG by Shekarsarai, H, Zlotta, A R, Drowart, A, Van Vooren, J P, De Cock, M, Pirson, M, Palfliet, K, Jurion, F, Vanonckelen, A, Simon, J, Schulman, C C, Huygen, K

    Published in Acta urologica Belgica (01-03-1997)
    “…Optimal duration of immunotherapy treatment by BCG for the prevention of recurrences of superficial bladder cancer is still unknown. We have studied the…”
    Get more information
    Journal Article